-+ 0.00%
-+ 0.00%
-+ 0.00%

U.S. FOOD AND DRUG ADMINISTRATION APPROVES EXPANDED INDICATION FOR BRISTOL MYERS SQUIBB’S CAMZYOS® (MAVACAMTEN) FOR THE TREATMENT OF SYMPTOMATIC OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY (OHCM) IN ADULTS AND PEDIATRIC PATIENTS*

Reuters·09/30/2026 21:32:00

Please log in to view news